The use of microarray technology in the management of breast cancer

Clinical Advances in Hematology and Oncology

Volumn 5, Issue 3, 2007, Pages 193-197

  Pusztai, Lajos ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE INHIBITOR; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FLUOROURACIL; PACLITAXEL; TAMOXIFEN; TRASTUZUMAB;

ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER HORMONE THERAPY; CANCER STAGING; CANCER SURVIVAL; CELL FUNCTION; CLINICAL TRIAL; DIAGNOSTIC VALUE; DISEASE SEVERITY; DNA MICROARRAY; DRUG COST; DRUG EFFICACY; DRUG RESPONSE; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; HUMAN; IMMUNOHISTOCHEMISTRY; MEDICAL DECISION MAKING; MICROARRAY ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CLINICAL TRIALS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 34247478093     PISSN: 15430790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. MAQC consortium. The microarray quality control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol. 2006;24:1151-1161.
2. Buyse M, Loi S, van't Veer L, et al. Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer. J Natl Cancer Inst. 2006;98:1183-1192.
3. Paik S, Shak S, Tang G et al. A multi gene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med. 2004;351:2817-2826.
4. Hess KR, Anderson K, Symmans W, et al. Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer. J Clin Oncol. 2006;24:4236-4244.
5. Dupuy A, Simon RM. Critical review of published microarray studies for cancer outcome and guidelines on statistical analysis and reporting. J Natl Cancer Inst. 2007;99:147-157.